======= HHEX ======= == Gene Information == * **Official Symbol**: HHEX * **Official Name**: hematopoietically expressed homeobox * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3087|3087]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q03014|Q03014]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HHEX&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HHEX|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604420|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Recognizes the DNA sequence 5'-ATTAA-3'. Transcriptional repressor. May play a role in hematopoietic differentiation. Establishes anterior identity at two levels; acts early to enhance canonical WNT-signaling by repressing expression of TLE4, and acts later to inhibit NODAL-signaling by directly targeting NODAL (By similarity). {ECO:0000250}. |Homeobox| |negative regulation of transcription by transcription factor localization| |eukaryotic initiation factor 4E binding| |negative regulation of transcription by competitive promoter binding| |negative regulation of vascular endothelial growth factor receptor signaling pathway| |DNA binding, bending| |poly(A)+ mRNA export from nucleus| |TBP-class protein binding| |negative regulation of cyclin-dependent protein serine/threonine kinase activity| |negative regulation of cyclin-dependent protein kinase activity| |regulation of vascular endothelial growth factor receptor signaling pathway| |repressing transcription factor binding| |protein-DNA complex| |regulation of cyclin-dependent protein serine/threonine kinase activity| |regulation of cyclin-dependent protein kinase activity| |negative regulation of angiogenesis| |negative regulation of blood vessel morphogenesis| |B cell differentiation| |mRNA-containing ribonucleoprotein complex export from nucleus| |mRNA export from nucleus| |negative regulation of vasculature development| |ribonucleoprotein complex export from nucleus| |ribonucleoprotein complex localization| |RNA export from nucleus| |negative regulation of protein serine/threonine kinase activity| |negative regulation of cellular response to growth factor stimulus| |protein export from nucleus| |B cell activation| |mRNA transport| |nuclear export| |protein localization to nucleus| |positive regulation of Wnt signaling pathway| |nucleic acid transport| |RNA transport| |establishment of RNA localization| |anterior/posterior pattern specification| |RNA localization| |transcription regulatory region DNA binding| |regulation of leukocyte proliferation| |negative regulation of protein kinase activity| |lymphocyte differentiation| |nucleobase-containing compound transport| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |negative regulation of kinase activity| |protein-containing complex localization| |nucleocytoplasmic transport| |nuclear transport| |regulation of cellular response to growth factor stimulus| |negative regulation of transferase activity| |regulation of angiogenesis| |DNA conformation change| |RNA polymerase II regulatory region sequence-specific DNA binding| |regulation of vasculature development| |leukocyte differentiation| |transcription factor binding| |regionalization| |Wnt signaling pathway| |cell-cell signaling by wnt| |regulation of Wnt signaling pathway| |lymphocyte activation| |response to peptide hormone| |negative regulation of protein phosphorylation| |sequence-specific DNA binding| |cell surface receptor signaling pathway involved in cell-cell signaling| |pattern specification process| |negative regulation of phosphorylation| |response to peptide| |RNA polymerase II proximal promoter sequence-specific DNA binding| |regulation of protein serine/threonine kinase activity| |hemopoiesis| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |response to wounding| |negative regulation of cell cycle| |negative regulation of protein modification process| |hematopoietic or lymphoid organ development| |immune system development| |protein localization to organelle| |negative regulation of catalytic activity| |regulation of protein kinase activity| |negative regulation of transcription by RNA polymerase II| |regulation of kinase activity| |protein homodimerization activity| |response to hormone| |leukocyte activation| |negative regulation of developmental process| |regulation of transferase activity| |intracellular protein transport| |response to organonitrogen compound| |negative regulation of cellular protein metabolic process| |regulation of anatomical structure morphogenesis| |chromosome organization| |cell activation| |response to nitrogen compound| |negative regulation of protein metabolic process| |cell-cell signaling| |negative regulation of molecular function| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |regulation of protein phosphorylation| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |protein transport| |negative regulation of cellular biosynthetic process| |intracellular transport| |peptide transport| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |DNA-binding transcription factor activity, RNA polymerase II-specific| |amide transport| |cellular protein localization| |regulation of phosphorylation| |cellular macromolecule localization| |establishment of protein localization| |regulation of cell population proliferation| |negative regulation of response to stimulus| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |establishment of localization in cell| |regulation of protein modification process| |nitrogen compound transport| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp278|CVT-10216 0.1μM R06 exp278]]|-1.85| |[[:results:exp153|SGC2096 2.6μM R03 exp153]]|-1.78| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|1.75| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|1.83| |[[:results:exp531|THZ1 0.06μM R08 exp531]]|1.83| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|2.02| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|2.04| |[[:results:exp515|PU-H71 1μM R08 exp515]]|2.26| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|2.56| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|2.69| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.538| |[[:human genes:m:mllt1|MLLT1]]|0.51| |[[:human genes:t:trim28|TRIM28]]|0.491| |[[:human genes:o:otud5|OTUD5]]|0.48| |[[:human genes:m:meaf6|MEAF6]]|0.467| |[[:human genes:t:thoc6|THOC6]]|0.454| |[[:human genes:i:id3|ID3]]|0.449| |[[:human genes:n:nsd1|NSD1]]|0.447| |[[:human genes:u:ube2l3|UBE2L3]]|0.446| |[[:human genes:c:ccdc101|CCDC101]]|0.44| |[[:human genes:r:rptor|RPTOR]]|0.434| |[[:human genes:u:usp22|USP22]]|0.434| |[[:human genes:z:znf592|ZNF592]]|0.431| |[[:human genes:m:mtor|MTOR]]|0.429| |[[:human genes:u:ubr5|UBR5]]|0.428| |[[:human genes:t:tle4|TLE4]]|0.426| |[[:human genes:f:fbxo11|FBXO11]]|0.424| |[[:human genes:b:brpf1|BRPF1]]|0.424| |[[:human genes:n:nxt1|NXT1]]|0.423| |[[:human genes:c:csnk2b|CSNK2B]]|0.417| |[[:human genes:v:vcpip1|VCPIP1]]|0.416| |[[:human genes:a:atf7ip|ATF7IP]]|0.414| |[[:human genes:m:med13l|MED13L]]|0.409| |[[:human genes:i:irf2bp2|IRF2BP2]]|0.406| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4158 * **Expression level (log2 read counts)**: 4.37 {{:chemogenomics:nalm6 dist.png?nolink |}}